Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid Tumors
NCT07657611
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Neoplasms
Solid Tumors
Neoplasm Metastasis
Interventions
BIOLOGICAL:
Inhaled mRNA
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences